(Photo Credit: whiteMocca/Shutterstock)
Enzo Biochem class action lawsuit overview:
- Who: Plaintiff Paula Magnani filed a class action lawsuit against Enzo Biochem Inc. and Enzo Clinical Labs Inc.
- Why: The defendants allegedly failed to adequately safeguard sensitive data, leaving the information vulnerable to a cyberattack that may have affected the data of nearly 2.5 million individuals.
- Where: The Enzo Biochem class action lawsuit was filed in New York federal court.
Nearly 2.5 million individuals may be affected by a recent cyberattack in which unauthorized criminals accessed sensitive data from Enzo Biochem, according to a class action lawsuit filed June 26 in New York federal court.
Plaintiff Paula Magnani filed the class action lawsuit on behalf of herself and others whose information was compromised in the Enzo Biochem data breach.
Enzo Biochem is a New York-based life sciences and biotechnology company, and its wholly-owned subsidiary Enzo Clinical is a full-service clinical reference laboratory, Magnani explains.
The personally identifying information (PII) and protected health information (PHI) that may have been compromised in the Enzo Biochem data breach included names, clinical health information, dates of service, and Social Security numbers.
Enzo Biochem class action says company maintained sensitive data in ‘negligent’ or ‘reckless’ manner
The data breach class action lawsuit notes that Enzo Biochem is a HIPAA covered entity and is thus required to implement safeguards to prevent the unauthorized disclosure or use of private information and to report any unauthorized use or disclosure of the private information.
Magnani says Enzo Biochem maintained class members’ PII and PHI “in a negligent and/or reckless manner,” leaving the information stored on its computer system and network “in a condition vulnerable to cyberattacks.”
To make matters worse, the Enzo Biochem class action lawsuit alleges the defendants waited nearly two months to notify affected individuals after they learned about the cyberattack and data breach, preventing class members from taking quick action to protect their sensitive information.
Magnani notes that data thieves can use the information obtained in the Enzo Biochem data breach to commit a number of crimes in the class members’ names, including opening new financial accounts, taking out loans, obtaining medical services, filing fraudulent tax returns, and obtaining driver’s licenses.
Due to the Enzo Biochem data breach, Magnani says that she and the other putative class members “face a substantial risk of imminent and certainly impending harm.”
The Enzo Biochem class action lawsuit asserts claims for negligence, breach of implied contract, unjust enrichment, breach of fiduciary duty, and bailment.
Earlier this month, Verizon Wireless released its 2023 Data Breach Investigations Report, which found that human error plays a significant role in ransomware attacks and data breaches, which are becoming more frequent and costly.
Was your information compromised in the Enzo Biochem data breach? Tell us your story in the comments!
Magnani is represented by Steven M. Nathan, James J. Pizzirusso, and Amanda V. Boltax of Hausfeld LLP; Kim D. Stephens and Cecily C. Jordan of Tousley Brain Stephens PLLC; and Amy Keller of DiCello Levitt LLP.
The Enzo Biochem data breach class action lawsuit is Paula Magnani v. Enzo Biochem Inc., et al., Case No. 2:23-cv-04749, in the U.S. District Court for the Eastern District of New York.
We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.
The post Enzo Biochem class action claims biotech company failed to prevent data breach appeared first on Top Class Actions.
